HomeOpen Access NewsDrug Development

Drug Development

UCL leads €60m AI-driven drug discovery project launch

UCL joins global €60m AI-driven drug discovery initiative to generate open datasets and accelerate new medicines using AI models across disease areas.

US healthcare: 34% of older people could be prescribed the wrong drugs

A new study found that it costs patients over $450 a year when they are prescribed the wrong drugs, making them twice as likely to go to hospital.

Research finds cannabis could reduce OCD symptoms by 50%

OCD symptoms could be eased by atleast half in the short-term, according to a new study published in the Journal of Affective Disorders.

EUMCA: Medical cannabis and research collaboration after Brexit

Here, we talk to Professor Trevor Jones at the European Medical Cannabis Association (EUMCA) about storing CBD, clinical trials post-Brexit and the UK-US trade deal.

Antimicrobial resistance: The next big pandemic?

Josep Figueras and Anna Sagan from the European Observatory on Health Systems and Policies focus here on antimicrobial resistance and ponder whether or not this could be the next big pandemic.

Ensuring a high and reproducible quality of medicinal cannabis

Renata Mala, PharmD, Chairman of Purely Plant GmbH, underlines the importance of ensuring high and reproducible quality when it comes to medicinal cannabis.

COVID-19 and pulmonary fibrosis

Steve Jones, President of EU-IPFF and Chair, Action for Pulmonary Fibrosis in the UK describes the connection between COVID-19 and pulmonary fibrosis.

New drug offers promising treatment for pancreatic cancer patients

Scientists have invented a new drug which could improve life expectancy and quality for patients with hard-to-treat cancers, such as pancreatic cancer.

Finding new antibiotics: The genome way

Professor Tilmann Weber discusses how microbial genomics helps to find the next generation of antibiotics in the race against antimicrobial resistance.

Cambridge COVID-19 vaccine gets £1.9 million to start trials

The University of Cambridge are developing a COVID-19 vaccine, which is expected to start clinical trials in Autumn 2020.

Nightingale hospitals could increase antibiotic resistance

The University of Plymouth revealed that secondary COVID-19 treatment could be increasing antibiotic resistance and polluting water.

New cell injection technique could reverse vision loss

Researchers at the University of Toronto Engineering tried co-injection of both retinal pigmented epithelium (RPE) cells and photoreceptor cells to reverse vision loss.

Male bias in drug development trials creates overmedication

New research shows that the gender gap in drug development trials results in an overmedication of women by healthcare professionals.

21 drugs that could help to treat COVID-19

A study recently identified 21 existing drugs that could improve the effect of remdesivir.

Genetic variant acts as a natural epidural, relieving pain in childbirth

Scientists at the University of Cambridge have discovered a genetic variant that acts as a natural epidural, explaining why some women do not need pain relief during childbirth.

Blood iron levels could be the reason behind slow ageing

Scientists from the University of Edinburgh and Max Planck Institute for Biology of Ageing identify blood iron levels as an ageing factor.

Can nanoparticles change lung cancer treatment?

A promising idea for lung cancer treatment has been developed by researchers at Lund University.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders